The News Review:
- ICRI opens fifth campus at Cavendish College
- Intas Pharma may offload 10% to raise Rs200 cr from market
- Friedrich Luft Received Novartis Award For His Research n Hypertensio…
- New biotech centre to create industrial partnerships
ICRI opens fifth campus at Cavendish College
Times of India – Sep 29, 2007
The new course isunique as it will include regulations for clinical research in Europe US Japanand India says a release. This will help in producing professionals for globalmarket. It will be a part-time course and the first batch will start in Februarywith 40 students. The faculty will be from USA Europe UK and India.
Intas Pharma may offload 10% to raise Rs200 cr from market
Livemint – Sep 29, 2007
Intas has drugs in chronic therapy segments of central nervous system cardiovascular diabetology gastroentrology urology and pain management. It has a presence in South-East Asia Africa and a small presence in the US Europe and Latin America. It also has affiliates in the fast growing segments of contract clinical research and biotechnology?Astron Research Ltd Lambda Therapeutic Research Ltd and Intas Biopharmaceuticals Ltd. Private equity firm ChrysCapital which had bought a 12. 5% stake in the company in January 2006 for roughly Rs53 crore will stay invested and not exit as part of the public issue the person close to the share sale said. As big drug makers have focused largely on overseas markets to raise money in the form of foreign currency convertible bonds or depositary shares it is only small drug firms such as Intas that have turned to Indian bourses. Drug makers that have raised money this year include Celestial Labs Ltd which raised Rs30 crore SMS Pharmaceuticals Ltd (Rs110 crore) Alpa Laboratories Ltd (Rs57 crore) and Saamya Biotech (India) Ltd (Rs15 crore).
Friedrich Luft Received Novartis Award For His Research n Hypertensio…
Medical News Today – Medical News Today (press release) – Sep 29, 2007
The research fellowship program that he established between that institution and the MDC is one of his most important accomplishments in his opinion. Luft was also elected member to the German Academy of Sciences Leopoldina. Friedrich Luft is the third physician and researcher of Germany to receive the Novartis award. The two others are Detlev Ganten (1992 at that time the Ciba Award) and Franz Gross (1969 at that time the Stouffer Prize).
New biotech centre to create industrial partnerships
New Europe – Sep 29, 2007
The new Bio Centre houses the experimental research units of the Capital Region of Denmark. The aim is that the construction is to be extended with a science park comprising smaller start ups within the knowledge intensive industry. “When we establish pure research clinical research applied research and education under the same roof there is a better chance of creating the supply chain that enables us to deliver to the industry” said Lene Lange leader of the Institute for Molecular Biology which is Denmark’s largest biological institute. “I believe that by creating such environment we will succeed at getting direct interaction between new biotech companies large well-established biotech and pharma companies and the researchers” he said.
